RecruitingNCT07280364
Metabolomics in the Diagnosis and Treatment of Asthma in Children
Sponsor
I.M. Sechenov First Moscow State Medical University
Enrollment
100 participants
Start Date
Mar 13, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
The goal of this observational study is to learn about the metabolomic profile of blood and urine in children 12-17 years with asthma. The main question it aims to answer is: • Are there metabolites in the blood and urine that are specific for asthma exacerbation? Participants already receive standard therapy as part of their regular medical care for asthma.
Eligibility
Min Age: 12 YearsMax Age: 17 Years
Inclusion Criteria3
- Age from 12 to 17 years old
- Confirmed diagnosis of asthma
- Informed voluntary consent to participate in the study
Exclusion Criteria4
- age under 12 years
- no established diagnosis of asthma
- concomitant severe somatic, metabolic, and endocrine diseases
- patient's withdrawal of informed consent
Interventions
DRUGStandart medical treatment
No intervention, patients will recieve standard medical treatment
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07280364
Related Trials
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
NCT06664619138 locations
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
NCT06052267393 locations
Use of Biologics for Severe Asthma in Hong Kong
NCT067787461 location
Relationship of Airway Microbiota, Endotype and Phenotype in Adult Asthma
NCT047069881 location
Genetic Association With Various Severities, Phenotypes and Endotypes of Asthma.
NCT061960342 locations